DERM

Journey Medical Corp

• Reuters·03/31 20:18

  CORRECTED-Fortress Biotech 2025 revenue rises, net loss narrows

• TipRanks·03/27 00:24

  Journey Medical Rides Emrosi Surge Toward Profitability

• NASDAQ·03/26 20:30

  Journey Medical (DERM) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

• Benzinga·03/26 17:05

  12 Health Care Stocks Moving In Thursday's Intraday Session

• TipRanks·03/26 13:55

  Journey Medical Corp (DERM) Gets a Buy from Alliance Global Partners

• TipRanks·03/26 12:51

  Journey Medical price target raised to $12 from $11 at B. Riley

• TipRanks·03/26 12:50

  Analysts Offer Insights on Healthcare Companies: Journey Medical Corp (DERM), Quoin Pharmaceuticals (QNRX) and SeaStar Medical Holding (ICU)

• Dow Jones·03/26 09:44

  Journey Medical Price Target Maintained With a $13.00/Share by HC Wainwright & Co.

• Benzinga·03/26 09:33

  HC Wainwright & Co. Reiterates Buy on Journey Medical, Maintains $13 Price Target

• TipRanks·03/26 05:00

  Analysts Offer Insights on Healthcare Companies: Icon (ICLR) and Journey Medical Corp (DERM)

• Seeking Alpha·03/26 02:46

  Journey Medical targets expanded Emrosi coverage and EBITDA growth through 2026 amid robust prescription demand

• TipRanks·03/25 22:35

  Closing Bell Movers: Navan jumps over 20% after results

• TipRanks·03/25 22:20

  Journey Medical reports FY25 EPS (47c) vs. (72c) last year

• Dow Jones·03/25 22:09

  Journey Medical Shares Retreat After Annual Revenue Misses Wall Street's Estimate

• Reuters·03/25 20:03

  Journey Medical FY2025 net loss narrows to $(0.47) per share; revenue rises 10% to $61.9 million